NOW ENROLLING
SUMAS Admission
Biopharmaceuticals (protein therapeutics) and applications., Enzymes, receptors and the action of small molecule drugs, The small molecule drug discovery process- from target selection to candidate selection, discovery and use of biopharmaceuticals and small molecule chemotherapeutics, The structure and business of biopharmaceutical companies including management of risks and resources; Candidate molecules for therapies e.g., for diseases like type II diabetes, hormonal replacement therapy and anti-TNF agents. Discovery and development of anti-cancer agents via the inhibition of the epidermal growth factor receptor tyrosine kinase, targeting HER2 by monoclonal antibodies for cancer therapy, recombinant human erythropoietin and its analogues, lysosomal protein disorders-current treatments and future directions.